Cargando…
Clinical Significance of Molecular Alterations and Systemic Therapy for Meningiomas: Where Do We Stand?
SIMPLE SUMMARY: Meningiomas are the most frequent intracranial tumors and comprise a heterogeneous spectrum of diseases, ranging from small, asymptomatic tumors that do not need treatment to large, symptomatic ones causing seizures or neurological deficits that require surgery and/or radiotherapy. S...
Autores principales: | Pellerino, Alessia, Bruno, Francesco, Palmiero, Rosa, Pronello, Edoardo, Bertero, Luca, Soffietti, Riccardo, Rudà, Roberta |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9100910/ https://www.ncbi.nlm.nih.gov/pubmed/35565385 http://dx.doi.org/10.3390/cancers14092256 |
Ejemplares similares
-
Glioblastoma in the Elderly: Review of Molecular and Therapeutic Aspects
por: Bruno, Francesco, et al.
Publicado: (2022) -
Elderly Gliobastoma Patients: The Impact of Surgery and Adjuvant Treatments on Survival: A Single Institution Experience
por: Bruno, Francesco, et al.
Publicado: (2022) -
Neoplastic meningitis in solid tumors: from diagnosis to personalized treatments
por: Pellerino, Alessia, et al.
Publicado: (2018) -
Targeted Therapies in Rare Brain Tumours
por: Bruno, Francesco, et al.
Publicado: (2021) -
Neratinib and Capecitabine for the Treatment of Leptomeningeal Metastases from HER2-Positive Breast Cancer: A Series in the Setting of a Compassionate Program
por: Pellerino, Alessia, et al.
Publicado: (2022)